Screener
Arcutis Biotherapeutics, Inc. ARQT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Trade receivables, net | 155,162 | 146,229 |
| Inventory | 38,879 | 22,634 |
| Prepaid expenses and other current assets | 34,770 | 21,079 |
| Total current assets | 467,671 | 411,232 |
| Property, plant, and equipment, net | 872 | 1,043 |
| Intangible assets, net | 13,687 | 14,812 |
| Operating lease right-of-use asset | 4,253 | 4,467 |
| Other assets | 2,054 | 1,419 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s total current assets?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total current assets of $467.67M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s total current assets changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total current assets increased by 40.5% year-over-year, from $332.78M to $467.67M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s total current assets has grown at a 7.0% compound annual growth rate (CAGR), from $292.83M to $411.23M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Arcutis Biotherapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude